eyenovia-logo 3

SEC Filings

EYENOVIA, INC. filed this Form EFFECT on 12/18/2018
Document Outline
Entire Document (597 Bytes)
Subdocument 1 - EFFECT

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

New York    501 Fifth Avenue, Suite 1404 New York NY 10017     +1 (917) 289-1117

[email protected]